The state-of-the-art Accu-Chek® Mobile system makes handling used lancets and test strips a thing of
the past
MONTREAL, April 28 /CNW Telbec/ - Roche Diagnostics Canada, a
trailblazer in the healthcare field, is proud to introduce Accu-Chek® Mobile, the first strip-free blood glucose monitoring device available
on the market. The state-of-the-art Accu-Chek® Mobile system eliminates the need to handle used lancets and test
strips. Specially developed for people living with diabetes, the device
yields accurate, reliable blood glucose readings within five seconds,
making it a particularly practical solution for users of rapid-acting
insulin.
For the 3 million Canadians with diabetes, and especially the 10% who
have type 1 diabetes, the new Accu-Chek® Mobile glucose monitoring device provides, at long last, a quick,
simple way of checking blood glucose levels. '' For people who live
with diabetes, there are many daily steps involved in managing their
disease, says Lori Berard, RN CDE Nurse Manager at the University of
Manitoba's Diabetes Research Center. For someone who has not had
diabetes touch their lives, it may appear as though a blood glucose
checking is a rather simplistic task, but it is rather complex.
Lightweight and portable, the device features a unique test cassette
pre-loaded with a continuous testing tape and a lancet drum. It also
boasts a simplified three-step testing process, compared with the
average 11 steps required with single strip devices. Accu-Chek® Mobile allows users to perform up to 50 tests before replacing the
cassette. The fast, convenient device provides readings within five
seconds, with only a minimal blood sample, thanks to the improved
Accu-Chek FastClix lancet system. "This type of system will make
monitoring blood glucose easier, and much more efficient," states
Berard.
Accu-Chek® Mobile can also store up to 500 readings as well as averages over 7, 14
and 30 days, enabling users to consult their testing history and thus
allow them to better manage their blood glucose levels over time.
Moreover, data from the device can be uploaded to Excel or Accu-Chek® software for tracking purposes.
Roche's Accu-Chek® Mobile blood glucose monitoring device is now available in drug stores
at the suggested retail price of $75. For further information, go to www.accu-chek.ca.
About Roche
Headquartered in Basel, Switzerland, Roche is a leader in
research-focused healthcare with combined strengths in pharmaceuticals
and diagnostics. Roche is the world's largest biotech company with
truly differentiated medicines in oncology, virology, inflammation,
metabolism and CNS. Roche is also the world leader in in-vitro
diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes
management. Roche's personalized healthcare strategy aims at providing
medicines and diagnostic tools that enable tangible improvements in the
health, quality of life and survival of patients. In 2010, Roche had
over 80,000 employees worldwide and invested almost 9 billion Swiss
francs in R&D. The Group posted sales of 47.5 billion Swiss francs.
Genentech, United States, is a wholly owned member of the Roche Group.
Roche has a majority stake in Chugai Pharmaceutical, Japan. For more
information: www.roche.com.
All trademarks used or mentioned in this release are legally protected.
Image with caption: "Accu-Chek® Mobile, the world's first strip-free blood glucose monitoring device. (CNW Group/Roche Diagnostics)". Image available at: http://photos.newswire.ca/images/download/20110428_C7757_PHOTO_EN_01.jpg
Email this
Share on Facebook
